Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) induced cytokine storm is
the major cause of COVID-19 related deaths. Patients have been treated with drugs that …

Abstract Although 15–20% of COVID‐19 patients experience hyper‐inflammation induced
by massive cytokine production, cellular triggers of this process and strategies to target them …

As the number of novel coronavirus (COVID-19) cases continues to rise, there is a global
need for rapid drug development. In this study, we propose a systems pharmacology …

Background Drug repurposing is a fast and effective way to develop drugs for an emerging
disease such as COVID-19. The main challenges of effective drug repurposing are the …

In recent years, machine learning (ML) techniques have garnered considerable interest for
their potential use in accelerating the rate of drug discovery. With the emergence of the …

Abstract Treatment options for COVID‐19, caused by SARS‐CoV‐2, remain limited.
Understanding viral pathogenesis at the molecular level is critical to develop effective …

Abstract SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a novel virus in
the family of Coronaviridae. The virus causes COVID-19, an infectious disease. SARS-CoV …

The outbreak of the novel coronavirus severe acute respiratory syndrome‐coronavirus 2
(SARS‐CoV‐2), the causative agent of coronavirus disease 2019 (COVID‐19) respiratory …

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
global pandemic and emergency. Currently, there is no therapeutic agent that has been …

Background The coronavirus disease-19 (COVID-19) emerged in Wuhan, China and rapidly
spread worldwide. Researchers are trying to find a way to treat this disease as soon as …